Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

den Besten-Berthololee D

36 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 14 Safety 13 Review Article 11 Clinical Trial 7 Observational Study 7 Consciousness 6 Addiction 6 Adverse Events 5 Anxiety 4 Wellbeing 4 General 4 Emotional Processing 3

Journals

PsyArXiv 5 Psychedelic medicine (New Rochelle, N.Y.) 2 JAMA psychiatry 2 Frontiers in psychology 2 International Journal of Drug Policy 1 Psychopharmacology 1 Psychiatry research 1 medRxiv 1

Publication history

Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-09-01 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28 Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.Psychiatry research · 2026-05-01 Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety RecommendationsmedRxiv · 2026-04-30 Psilocybin use among Basotho healers and non-healers in southern AfricaOSF Preprints · 2026-04-23 Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.BMJ supportive & palliative care · 2026-02-27 Psychedelic medicine: mechanisms, evidence, and translation to practice.BMJ (Clinical research ed.) · 2026-02-23 Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01 Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.The Lancet. Child & adolescent health · 2025-10-01 Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention StudiesWellcome Open Res · 2025-07-08 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Associations between psychedelic use and cannabis use disorder in a nationally representative sample.Drug and alcohol dependence · 2025-01-01 Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.Journal of psychoactive drugs · 2025-01-01 Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.AJOB empirical bioethics · 2025-01-01 Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.JAMA psychiatry · 2024-12-01 Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.International review of psychiatry (Abingdon, England) · 2024-12-01 Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.JAMA psychiatry · 2024-06-01 Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.Cancer · 2024-04-01 IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.Pharmacological research · 2024-01-01 Valuing the Acute Subjective Experience.Perspectives in biology and medicine · 2024-01-01 Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.AJOB neuroscience · 2024-01-01 [Feeling unwell after eating a piece of chocolate].Nederlands tijdschrift voor geneeskunde · 2023-11-23 Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.Journal of psychopharmacology (Oxford, England) · 2023-07-01 Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees · 2023-06-27 Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09 Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01 Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28 Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01 The Potential of Psychedelics for End of Life and Palliative Care.Current topics in behavioral neurosciences · 2022-01-01 Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.Frontiers in psychology · 2022-01-01 The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.Frontiers in psychology · 2022-01-01 Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.The International journal on drug policy · 2021-12-01 Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.The international journal of neuropsychopharmacology · 2021-08-20 EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.Pharmacology, biochemistry, and behavior · 1980-01-01

Author directory